Clinical Trials Browser

Phase 2 × Terminated × enfortumab vedotin × Clear all

NCT05097599 2025-01-08

StrataPATH

Phase 2 Terminated

Neoplasms

NCT03606174 2023-08-24

A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma

Phase 2 Terminated

260 enrolled 28 charts

Carcinoma, Transitional Cell